323 related articles for article (PubMed ID: 2308219)
21. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
23. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
[TBL] [Abstract][Full Text] [Related]
24. Clinical and experimental aspects of hormone receptors in breast carcinoma patients.
Spona J; Kolb R; Reiner G; Jakesz R; Moser K; Rainer H
Cancer Detect Prev; 1983; 6(1-2):227-34. PubMed ID: 6883382
[TBL] [Abstract][Full Text] [Related]
25. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
26. Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.
Chang J; Powles TJ; Allred DC; Ashley SE; Makris A; Gregory RK; Osborne CK; Dowsett M
Clin Cancer Res; 2000 Feb; 6(2):616-21. PubMed ID: 10690547
[TBL] [Abstract][Full Text] [Related]
27. Progesterone and estrogen receptors as prognostic variables in breast cancer.
Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
29. [The status of hormone therapy in breast cancer in 2001?].
Boussen H; Bouaouina N; Rahal F; Benna F
Tunis Med; 2002 Jul; 80(7):359-64. PubMed ID: 12611343
[TBL] [Abstract][Full Text] [Related]
30. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
Izuo M; Iino Y
Gan No Rinsho; 1983 May; 29(6):637-43. PubMed ID: 6876433
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
32. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
Stendahl M; Rydén L; Nordenskjöld B; Jönsson PE; Landberg G; Jirström K
Clin Cancer Res; 2006 Aug; 12(15):4614-8. PubMed ID: 16899609
[TBL] [Abstract][Full Text] [Related]
33. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
34. Steroid hormone receptors as prognostic indicators in primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; King WJ; DeSombre ER; Blough RM; Mouridsen HT; Rossing N; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S91-7. PubMed ID: 3527307
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
[TBL] [Abstract][Full Text] [Related]
36. Therapy for cancer of the breast. Current status of steroid hormone receptors.
Osborne CK; McGuire WL
West J Med; 1979 May; 130(5):401-7. PubMed ID: 516664
[TBL] [Abstract][Full Text] [Related]
37. Role of steroid hormone receptors as prognostic factors in primary breast cancer.
McGuire WL; Clark GM; Dressler LG; Owens MA
NCI Monogr; 1986; (1):19-23. PubMed ID: 3774012
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with prognosis in human breast cancer. V. The simultaneous use of estrogen and progesterone receptor measurements for prediction of short-term relapse.
Pascual MR; Macías A; Moreno L; Lage A
Neoplasma; 1985; 32(2):247-56. PubMed ID: 4000312
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
40. [The clinical significance of hormone receptors in the treatment of breast cancer].
Trams G
Fortschr Med; 1979 Apr; 97(14):641-4. PubMed ID: 437632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
